Opus Genetics, Inc. ( IRD) - Stock Earnings
IRD Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -17.5 million USD | 3.1 million USD |
| 2025Q4 | -16.5 million USD | 3.9 million USD |
| 2026Q1 | -65.5 million USD | 2.2 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
IRD Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -10.0 million USD | 19.0 million USD |
| 2024 | -57.5 million USD | 11.0 million USD |
| 2025 | -49.6 million USD | 14.2 million USD |
| 2026 Est. | — | — |
IRD
Price: $3.90
52 week price:
Earnings Per Share: -1.31 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 341.9 million